HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership.

Slides:



Advertisements
Similar presentations
What does sexual & reproductive health have to do with clinical trials? Providing contraception & reproductive health care helps.
Advertisements

No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
From “What If” to “What Now” Perspectives on ARVs and the Future of Treatment and Prevention Mitchell Warren Executive Director, AVAC IAS 2011, Rome.
1+1=3 FP/HIV Integration Africa SOTA June Purpose of This Session ˜Review key concepts of new guidance ˜Reality check-in through small group discussion.
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Hadiyah Charles, Community HIV/AIDS Mobilization Project Naina Khanna, WORLD/U.S. Positive Women’s Network HIV Research Catalyst Forum April 21, 2010.
© Aahung 2004 Millennium Development Goals Expanding the Agenda:
WORLD AIDS DAY 2001 Male involvement in the fight against AIDS Marleen Temmerman, RUG.
HIV and Reproductive Health? William Stones. Questions What is reproductive health? Is HIV best approached as a RH topic? What are the pros and cons of.
Women at Barcelona Satellite Meeting July 7, 2002 Prevention Panel Avni Amin, Ph.D. Senior Program Associate Center for Health and Gender Equity (CHANGE)
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Sexuality and Sexual Reproductive Health Laura Villa Torres Health Behavior and Health Education Gillings School of Global Public Health MSPH- PhD Student,
Expanding Safer Sex Options: Introducing the Female Condom Mitchell Warren The Female Health Company December 2001.
Female Condom: A Powerful Tool for Protection The IAWG on Reproductive Health in Crisis Settings Oct 8-10, Nairobi, Kenya.
Female Condom: A Powerful Tool for Protection Journalist to Journalist Training XVI International AIDS Conference Toronto August 2006.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
A generation of children free from AIDS is not impossible Children and AIDS Fourth Stocktaking Report, 2009.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
Voluntary Counseling and Testing (VCT) for HIV
STIs/HIV/AIDS. ( 2 ) Sexually transmitted infections (STIs) are spread primarily through sexual contact and are among the most common diseases in the.
Microbicide Research: A Promising HIV/AIDS Prevention Strategy for Women Roberta Black, Ph.D. Division of AIDS, National Institute of Allergy and Infectious.
Sexually Transmitted Infections & HIV/AIDS
EngenderHealth/UNFPA Project – Ethiopia/Ukraine Strengthening the integration of HIV prevention in maternal health services. Increasing the capacity of.
Introduction to Impact Evaluation: What is it and why do we use it? Male Circumcision Impact Evaluation Meeting Johannesburg, South Africa January 18-23,
Introduction to HIV New Prevention Technologies (NPTs)
Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,
Microbicide research in Africa: Partnership in Action Salim S. Abdool Karim, MD, PhD Director: CAPRISA Pro Vice-Chancellor (Research): University of KwaZulu-Natal.
Mobilizing for Reproductive Health/HIV Integration Reducing HIV Vulnerability and Impact for Women, Young Women & Girls Addis Ababa, February 2008.
Multipurpose Prevention Technologies What are they & why do we need them? [Presenter name, degree, affiliation] [Event title] [Date]
Biomedical Approaches to HIV Prevention HIV Research Catalyst Forum April 21, 2010, Baltimore, MD Monica S. Ruiz, PhD, MPH George Washington University.
The HIV virus. The overwhelming majority of people with HIV live in low- and middle-income countries. Sub- Saharan Africa accounts for two-thirds.
Empowering Women as a Development Tool Empowering Women: Sexual and Reproductive Health and Female Condoms Lucie van Mens
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
What Is Currently in the Pipeline & What is Ideal for an ARV-based Prevention Candidate? Carl W. Dieffenbach, Ph.D. Director, Division of AIDS, NIAID,
When Will Women Have Choices? Sharon Hillier University of Pittsburgh School and Medicine Microbicide Trials Network IAS, Washington DC, July 26, 2012.
AIDS 2012 Where are we, and where are we going? Mitchell Warren Executive Director, AVAC August 15, 2012.
GLOBAL UNITED CHILDREN’S FOUNDATION, Inc Presents “Using Education to Contain the Spread of HIV/AIDS in Africa and Expand Treatment in Rural Communities.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
INVESTING TO END THE AIDS EPIDEMIC: A NEW ERA FOR HIV RESEARCH & DEVELOPMENT HIV VACCINES WORKING GROUP & MICROBICIDES RESOURCE TRACKING E. Donaldson 1,
Female Condom: A Powerful Tool for Protection. Global Consultation on the Female Condom Review evidence for STI and pregnancy prevention Share program.
Keep your promise to women and girls Violence against Women and Girls in National AIDS plans.
Montreux, Switzerland, March 2007 New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications New Data on Male Circumcision and.
Eastern European Alliance for Reproductive Choice REPRODUCTIVE CHOICE FOR HIV- INFECTED WOMEN Prof. POSOKHOVA S.P. UKRAINE УКРАЇНАУКРАЇНА.
HIV/AIDS and Gender: South African Women and the Spread of Infection.
Session: 3 The four pronged approach to comprehensive prevention of HIV in infants and young children Dr.Pushpalatha, Assistant Professor, Dept of Pediatrics,
HIV/AIDS IN AFRICA- "The Orphaned Continent"
New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.
Effective HIV & SRH Responses among Key Populations Module 2: The Comprehensive Package of Programmes and Services.
A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009.
New Prevention Technologies Workshop Module 2: NPTs in context
What are HIV and AIDS? Human immunodeficiency virus (HIV) is a virus that destroys the immune system. The main target of HIV are CD4 cells, or helperT.
INITIATIVES OF HIGH LEVEL TASKFORCE FOR WOMEN, GIRLS, GENDER EQUALITY AND HIV FOR EASTERN AND SOUTHERN AFRICA TACAIDS.
Microbicides: New Hope for Prevention of HIV and other STIs Your name here
Prevention Science Gaps and the HIV/AIDS Pandemic Quarraisha Abdool Karim, PhD Head: CAPRISA Women and AIDS Pogramme Associate Professor in Epidemiology,
IAS Satellite Session 25th July 2017 Daniel Were, PhD
Dr. Monica Beg, Chief, HIV/AIDS Section, UNODC
WHO strategy on HIV/AIDS “Getting to Zero”
TransIT The Transgender Implementation Tool for the WHO key population guidelines.
New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications WHO/UNAIDS Technical Consultation on Male Circumcision and HIV.
On behalf of The MTN-020/ASPIRE Study Team
How does violence increase women’s vulnerability to HIV?
A public cervix announcement: CERVICAL BARRIERS in seven minutes
Every Mother, Every Child: Closing the Gaps in HIV Management
Gender & Health Melissa Watt, Ph.D. GLHLTH 310 October 23, 2012
2025 AIDS targets Technical meeting on prevention
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership for Microbicides July 6th

HIV Prevention – a neglected area Global HIV Prevention Working Group estimated that only 1 in 5 people at risk of HIV infection in developing countries had access to prevention services and commodities Global HIV Prevention Working Group estimated that only 1 in 5 people at risk of HIV infection in developing countries had access to prevention services and commodities Urgent need to scale up existing HIV treatment and prevention to reduce transmission rates and save lives. Urgent need to scale up existing HIV treatment and prevention to reduce transmission rates and save lives. However, even when scaled up, current treatments can prolong life, but they are not a cure. Present prevention options can reduce rates of HIV incidence but will not end the epidemic. However, even when scaled up, current treatments can prolong life, but they are not a cure. Present prevention options can reduce rates of HIV incidence but will not end the epidemic. With existing technologies and approaches, the global HIV/AIDS epidemic may be slowed but will continue to grow With existing technologies and approaches, the global HIV/AIDS epidemic may be slowed but will continue to grow

Women’s greater risk and urgent need for improved HIV prevention Biological: male-to-female transmission is easier than female-to-male Biological: male-to-female transmission is easier than female-to-male Economic: financial dependence on male partners Economic: financial dependence on male partners Cultural: early marriage, intergenerational sex and marital infidelity Cultural: early marriage, intergenerational sex and marital infidelity Sexual exploitation and violence Sexual exploitation and violence

Current prevention is failing us all but particularly women – why? Current prevention is failing us all but particularly women – why? Current approaches rely on individuals recognising and understanding their risk and on personal agency or ability to control or limit risk Current approaches rely on individuals recognising and understanding their risk and on personal agency or ability to control or limit risk Relies on individuals being empowered to employ various prevention strategies Relies on individuals being empowered to employ various prevention strategies Is increasingly based on morality as a guiding principle Is increasingly based on morality as a guiding principle

The world’s main HIV prevention technology is over 3000 years old

The Case for New Preventive Technologies One size does not fit all! One size does not fit all! Combination prevention is the future Combination prevention is the future If you increase the number of options available, the overall protection increases (lessons from family planning) If you increase the number of options available, the overall protection increases (lessons from family planning) We are not meeting people’s sexual and reproductive health needs. Ever rising number of infections confirm that we need to do things differently – including providing a wider range of tools. We are not meeting people’s sexual and reproductive health needs. Ever rising number of infections confirm that we need to do things differently – including providing a wider range of tools.

Female Barrier Methods Female condoms Female condoms –Contraception and STI prevention –High initial acceptability –Large programs in Brazil, Ghana, Namibia, South Africa, Zambia –Slow uptake Diaphragms Diaphragms –Contraceptive; STI prevention under study –Use currently low—0.3% of reproductive-age women in the US

What are cervical barriers (CBs)?

Diaphragms

Cervical Caps

Why cover the cervix? The cervix is fragile The cervix is fragile –Entrance lined with delicate columnar epithelial cells –This layer is only 1 cell thick Preferential site of infection for many STIs Preferential site of infection for many STIs –Bacterial pathogens (gonorrhea, chlamydia) –Human papilloma virus Concentration of HIV receptor sites Concentration of HIV receptor sites Protection of the upper genital tract Protection of the upper genital tract

Cervical barriers - summary Cervical barriers are long-standing, safe, effective female-controlled contraceptives. Cervical barriers are long-standing, safe, effective female-controlled contraceptives. Cervical barriers are currently being studied as potential STI/HIV prevention methods. Cervical barriers are currently being studied as potential STI/HIV prevention methods. New cervical barriers are under development. New cervical barriers are under development. May be a useful preventive method for women who do not wish to conceive. May be a useful preventive method for women who do not wish to conceive.

Microbicides Vaginal product to prevent or reduce HIV transmission Vaginal product to prevent or reduce HIV transmission Could potentially be delivered in many forms Could potentially be delivered in many forms A woman could initiate use independently to protect her health A woman could initiate use independently to protect her health Ideally safe, effective, low-cost and user- friendly Ideally safe, effective, low-cost and user- friendly

Why do we need a microbicide? Women are increasingly at risk of HIV globally and yet currently have no option that can be used without male consent or knowledge Women are increasingly at risk of HIV globally and yet currently have no option that can be used without male consent or knowledge Behavioural approaches are gender-blind Behavioural approaches are gender-blind Women have practical HIV prevention needs which must be met while gender equality is striven for Women have practical HIV prevention needs which must be met while gender equality is striven for Even a partially effective microbicide could have a huge impact on number of lives saved Even a partially effective microbicide could have a huge impact on number of lives saved

Early generation microbicides Non-specifically block HIV from interacting with target cells Non-specifically block HIV from interacting with target cells In most advanced stage of clinical trials (Carraguard, PRO2000, BufferGel) In most advanced stage of clinical trials (Carraguard, PRO2000, BufferGel) Partial, low or no effectiveness Partial, low or no effectiveness Short-acting (used near time of sex) Short-acting (used near time of sex)

Next generation microbicides Based on antiretroviral drugs (ARVs) with known efficacy in humans Based on antiretroviral drugs (ARVs) with known efficacy in humans Long half-life or can be formulated for sustained release Long half-life or can be formulated for sustained release Products may contain a combination of drugs that act at different stages of HIV replication Products may contain a combination of drugs that act at different stages of HIV replication

Delivery – offering choice Semisolids/Solids Semisolids/Solids –Gels –Vaginal Tablets –Films –Emulsions Devices Devices –Vaginal Ring –Sponge –Diaphragm

Why we need a vaccine Vaccines are essential in the prevention of epidemics Vaccines are essential in the prevention of epidemics Vaccines are the only intervention historically to have eradicated communicable disease Vaccines are the only intervention historically to have eradicated communicable disease Increased personal control over vulnerability to infection Increased personal control over vulnerability to infection An HIV vaccine should be seen as an important woman-initiated HIV prevention tool An HIV vaccine should be seen as an important woman-initiated HIV prevention tool Even a partially effective vaccine could play an important role in a comprehensive framework Even a partially effective vaccine could play an important role in a comprehensive framework

New Prevention Technologies Microbicides and vaccines will give people additional choices that better meet their needs in preventing HIV transmission. Microbicides and vaccines will give people additional choices that better meet their needs in preventing HIV transmission. In both cases, women can initiate use, and may be able to do so discretely, providing an essential benefit over existing prevention options. In both cases, women can initiate use, and may be able to do so discretely, providing an essential benefit over existing prevention options. Microbicide designs aim to address issues of intimacy and to provide choice over contraceptive function, which currently hinder greater condom uptake. Microbicide designs aim to address issues of intimacy and to provide choice over contraceptive function, which currently hinder greater condom uptake.

New Preventive Technologies A vaccine would not interfere with sex itself at all. A vaccine would not interfere with sex itself at all. Microbicides may offer the potential for efficacy against a range of other STIs Microbicides may offer the potential for efficacy against a range of other STIs HIV vaccines hold out the promise of an HIV prevention option not dependant on repeat use for every sexual or injecting drug use act. HIV vaccines hold out the promise of an HIV prevention option not dependant on repeat use for every sexual or injecting drug use act. A future vaccine could protect individuals from HIV infection before they become sexually active or begin other potentially high risk activities including intravenous drug use A future vaccine could protect individuals from HIV infection before they become sexually active or begin other potentially high risk activities including intravenous drug use

Prior to exposure Point of transmission After infection Male and female condoms Anti-retroviral therapy (mother-to- child) Post exposure prophylaxis (PEP) Anti-retroviral therapy Care Education & Behavioral change Education & Behavior change Preventive Vaccines Pre-exposure prophylaxis (PREP) Male circumcision HSV2 suppression Microbicides Diaphragm & other cervical barrier Therapeutic vaccines We need a comprehensive and integrated HIV/AIDS toolkit 4